Dalesandro Margaret
- SEC CIK
- 0001208853
No open-market purchases or sales filed in the past year.
Current role at each company
- AMAM Ambrx Biopharma, Inc.Directoras of Mar 7, 2024
- SKYE Skye Bioscience, Inc.Directoras of Mar 4, 2024
- SEEL Seelos Therapeutics, Inc.Directoras of Jan 8, 2024
- ONCS Oncosec Medical IncDirectoras of Aug 25, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Dalesandro Margaret as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
SEEL Seelos Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 27, 2022 (view filing) | May 26 | 1 day | Dalesandro MargaretDirector | PPurchase | +35.0K | $0.60 | +$21.0K | New position35.0K after |
ONCS Oncosec Medical Inc
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 25, 2021 (view filing) | Aug 23 | 2 days | Dalesandro MargaretDirector | PPurchase | +20.0K | $1.89 | +$37.8K | New position20.0K after |